Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Oral Etoposide vs Observation in Relapsed Germ-Cell Tumor
NCT04804007Phase 2Recruiting
- Start
- Mar 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide in germ cell tumor (GCT). Started Mar 2021; status: recruiting.
02
Drugs
etoposide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT04804007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804007.